Diagnosed with cancer after taking a Diabetes Medication?

Find out if you qualify for compensation by calling 888-990-2565 or clicking Get Started

Over $3B Recovered

Since 1993, our firm has recovered over $3 billion for our clients. We are a leader in litigating cases involving consumer products, dangerous drugs and defective medical devices.

National Representation

Based in New York, we represent clients across the United States. Regardless of your location, our award winning lawyers are ready to handle your Diabetes drug case.

No Recovery, No Fee

If we file your diabetic drug lawsuit, you will only pay attorneys’ fees if we make a recovery on your behalf. If no recovery is made you will not owe any legal fees.

What’s My Case Worth?

Depending on the extent of your injuries while taking a defective diabetic drug, you may be entitled to receive significant compensation for your injuries and other damages.

Recent Posts

Posted on: 05/15/2014 / Comments: 0 / Author: Reuben Kerben
A new study suggest incretin mimetic drug used to treat type 2 diabetes could significantly increase the risks of developing pancreatitis, pancreatic cancer, and thyroid cancer. Medications like Byetta and Januvia were included in the study. The U.S. Food and Drug Administration released an AdverseEvents Special Report for April 2014 in which researchers gathered public and non-public data to analyze the comparative safety of ...
Posted on: 02/23/2014 / Comments: 0 / Author: Reuben Kerben
Recent court documents reveal that both a master and short form complaint will now be used in the federal litigation involving Byetta lawsuits and other product liability lawsuits brought against the manufacturers of diabetes drugs called incretin mimetics. The federal multidistrict litigation involving Byetta, as well as Januvia and Victoza, is underway in the U.S. District Court, Southern District of California. An Order filed ...
Posted on: 12/27/2013 / Comments: 0 / Author: Reuben Kerben
Just-released court records indicate individuals who have filed federal Victoza and Janumet lawsuits will be permitted, under life threatening circumstances, to schedule early depositions in the consolidated litigation that is now underway in the U.S. District Court, Southern District of California The order was published on November 5th and includes established protocols for so-called “In Extremis” depositions. This ...
Posted on: 10/21/2013 / Comments: 0 / Author: Reuben Kerben
The nationwide litigation of Januvia, Janumet and Byetta lawsuit claims is continuing to grow rapidly with the scheduling of a status conference. According to reports, the federal proceeding pertains to incretin mimetics, and a state court trial in California is scheduled to begin November 2013. In the federal litigation established September 2013 in the U.S. District Court, Southern District of California, an Initial Conference ...

Obtaining Diabetes Drug Lawsuit Compensation

 Byetta warnings have also been issued by the U.S. Food & Drug Administration (FDA) over similar fears.

Byetta, Janumet, Januvia and Victoza  can cause pancreatitis, pancreatic cancer and thyroid cancer.

Diabetic drugs such as Byetta, Janumet, Januvia and Victoza fall into a class of medications known as incretin mimetics. These medications help to stimulate the insulin in the pancreas to help the patient better manage a dignosed type 2 diabetes condition. However, hundreds of plaintiffs are filing lawsuits against the manufacturers of these medications, claiming that the drugs cause adverse side effects and increases the risk of developing thyroid cancer, kidney complications and acute pancreatitis that can later lead to full pancreatic cancer.

According to the American Diabetes Association, over 25.8 million adults and children in the country are currently living with diabetes, 7 million people have yet to be diagnosed and 79 million individuals are in the pre-diabetic stage. With such drastically high numbers, it is no wonder that diagnosed diabetes cost over $245 billion in 2012 alone. Manufacturers are attempting to capitalize on the demand, creating medications to help patients manage their condition. However, studies, consumers and the healthcare community cite mounting evidence against these drugs, claiming that they are not safe for patients and that manufacturers neglected to identify and communicate the potential dangers and life-threatening side effects of their products in order to increase their own profits.

Pancreatic cancer is one of the deadliest forms of cancer.

Pancreatic cancer is the fourth leading cause of cancer related death for both men and women.

In fact, in one instance, the U.S. Food and Drug Administration asked one manufacturer to submit to further testing after receiving nearly 100 adverse event reports associated with the diabetic drug and while the manufacturer originally agreed, the company failed to follow through, showing just how devoted it was to the well-being of its consumers. There are currently no recalls of these medications, yet plaintiffs are still seeking compensation from the manufacturers for their injuries.

The lawyers at Bernstein Liebhard LLP have successfully recovered over $3 billion on behalf of our clients, and we have proven success when representing consumers across the United States against larger, multi-national corporations. We are here to assist victims that have been injured while taking defective diabetic drugs and work to obtain the maximum amount of compensation owed to you by law. If you have suffered from side effects or developed a serious health condition while taking these diabetic drugs, you may be entitled to file for medical bills, pain and suffering, lost wages and other damages. If you or someone you love are considering taking action, the time to act is limited; contact us today at (888) 990-2565 for a free, confidential case evaluation. If our firm accepts your case, you will not be obligated to pay any legal claims until a financial recovery is made.